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An asymmetric heterotopic ligand (NMeCP) containing a central bicyclic, expandedring NHC with one 
pyridyl and one phosphine substituent has been synthesised and its coordination chemistry with 
selected late transition metals investigated. The amidinium precursor [NMeCHP]PF6 shows variable 
coordination modes with Ag(I), Cu(I) and Au(I) depending on the L:M ratio. The reaction of two mols of 10 
[NMeCHP]PF6 with [Cu(MeCN)4]BF4, AgBF4 or Au(THT)Cl gives the ligand complexes [Cu(κ	
NMeCHP)2(CH3CN)2]BF4.(PF6)2, 1, and [M(κ	N
MeCHP)2]X.(PF6)2 (3: M = Ag, X = BF4; 6: M = Au, X 
= Cl) respectively. The 1:1 reaction of [NMeCHP]PF6 with AgOTf gave the headtotail dimer 

[Ag2(8	N
MeCHP)2(8OTf)2](PF6)2, 2, whereas the analogous reaction with Au(THT)Cl gave 
monomeric [Au(κ	NMeCHP)Cl]PF6, 5. Complex 2 was converted to 
[Ag2(8	N
MeCP)2](PF6)2, 15 
4, upon addition of base, while 6 gave [Au(κNMeCP)2]Cl, 8, when treated likewise. Reaction of [
NMeCHP]PF6 with Ni(1,5COD)2 gave the oxidative addition / insertion product [Ni(κ
3	
NMeCP)(η3C8H13)]PF6, 9, which converted to [Ni(κ
3	NMeCP)Cl]PF6, 10, upon exposure of a 
CHCl3 solution to air. Complex 10 showed conformational isomerism that was also present in [Rh(κ
3
	NMeCP)(CO)]PF6, 14, prepared from the precursor complex [Rh(κ	N
MeCHP)(acac)(CO)]PF6, 13, 20 
upon heating in C6H5Cl. [Pt(κ
3	NMeCP)(Cl)]PF6, 12, derived from [Pt(κ	
NMeCHP)2(Cl)2](PF6)2, 11, was isolated as a single conformer. 
Introduction 
The combination of two or more donor atoms of disparate 
character in a bi or multidentate ligand can generate complexes 25 
with unusual properties as each distinct donor will show variable 
binding to any given metal ion. Ligands that bind strongly 
through one or more primary donors with weak secondary 
donation are usually termed hemilabile and the transient 
coordination of the weak donor can assist catalytic processes 30 
through stabilization of reactive intermediates.1 There are 
numerous examples of this type of ligand with many different 
donor sets to include N/O, P/O, P/N, P/S and S/O combinations 
as heterotopic bidentate examples.2 Examples of NHeterocyclic 
carbenes (NHCs) with other donors are also numerous3 but very 35 
few combine an expandedring Nheterocyclic carbene (ER
NHC) with a phosphine,4 and of this extremely rare class, only 
those reported by our group feature an asymmetric element.4d,e 
Although often advantageous from a catalytic viewpoint, hemi
labile behavior is not always desirable (or possible) when 40 
employing heterotopic ligands. While we have an interest in 
hemilabile systems, our main focus is on the development of 
heterotopic ligands as frameworks for the control of metal
centered chirality in stereogenicatmetal complexes and/or to 
enable construction of homo and hetero bi and trimetallic 45 
species. Both these aims require robust metaldonor bonding to 
maintain configurational integrity. 
We have been investigating the coordination of linear tridentate 
systems with central expandedring Nheterocyclic carbene (ER
NHC) donors in an effort to understand what ligandmetal 50 
combinations favour chelate and/or bridging coordination modes. 
Our initial studies in the field focused on symmetrically 
substituted ligands of the type shown in figure 1 where the other 
donors are pyridines (NCN’ framework) or phosphines (PCP’ 
framework) respectively.4d,e,5 The distinctions between these two 55 
ligands are not solely confined to the different secondary donor 
atoms but extend to variations in the chelate ring sizes with the 
NCN’ systems forming two sixmembered, and the PCP’ type 
two sevenmembered, chelates upon κ3complexation. These 
discrepancies result in significant differences in their 60 
coordination chemistry with tetrahedral d10 metals preferring the 
PCP’ tridentates and square planar and fivecoordinate d8 metal 
ions favoring the NCN’ tridentates.4d,e,5 Configurational 
preferences were dictated by the nature of the halide in [Cu(κ3
PCP’)X] and were insignificant in [M(NCN’)(1,5COD]+ 65 
complexes where M = Rh, Ir. In addition, no conformational 
partiality was seen in square planar [Ni(NCN’)Cl]+ where a 1:1 
mixture of isomers was obtained.5 From this we deduced that the 
unadorned NCN’ and/or PCP’ frameworks were poor candidates 
for exerting the conformational control necessary for defining 70 
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configuration, and hence absolute stereochemistry, at a metal 
center. In order to promote the latter a further modification to one 
or both of the flanking arms was deemed necessary. The 
introduction of an additional stereocenter in one pyridyl arm of 
the NCN’ ligand to give the NMeCN’ derivative (Figure 1) was 5 
sufficient to achieve this.5a 
 
Figure 1. Previous examples of donorfunctionalized ERNHCs. 
 10 
The aforementioned ligands are of the ABA’ type where The A 
donors are equivalent and the discrimination between them lies at 
a (relatively) remote point. This is not the ideal as a ligand that 
contains three completely disparate donors (ABC type) and/or 
forms chelate rings of two different sizes is preferred. This 15 
combination is offered by the hybrid ligand NMeCP (figure 2) 
which has one pyridyl and one phosphine arm in addition to the 
central NHC group. The ligand also offers two different chelate 
ring sizes (a 6 and a 7membered) to embellish the chiral 
environment about the metal ion. The current paper reports some 20 
initial studies on the complexation of [NMeCHP]PF6 and 
NMeCP to metal ions of groups 9, 10 and 11.  
 
 
Figure 2. The NMeCP hybrid ligand 25 
Results and Discussion 
ligand synthesis 
Although a number of symmetrical PCP and NCN tridentate 
ligands are known,6,7 mixed donor ligands of the NCNHCP type 
discussed here are extremely rare.3a The inclusion of a single sp3 30 
carbon in each of the chelates of NMeCP was necessary to 
alleviate some of the strain associated with a sp2rich ligand 
backbone and to aid flexibility to encourage facial coordination. 
Residual strain does still exist so that facile breakage of one or 
both of the chelate ring(s) can occur and be exploited for the 35 
formation of bridged di(tri)metallic species. The nature of the 
coordination will be highly metal iondependent and the current 
work seeks to establish how both [NMeCHP]+ and NMeNCP 
behave towards a select number of transition metal ions. 
In order to restrict possible isomeric complexity during the 40 
coordination chemistry study (and to explore the limitations of 
stereocontrol in the metal systems), a single diastereomer(s) of 
the ligand was required. We have shown previously that 1,2,2
trimethyl3[1(pyridin2yl)ethyl]cyclopentane1,3diamine 
can be prepared stereoselectively through reduction of the mono45 
imine produced from condensation of 1,2,2
trimethylcyclopentane1,3diamine with (2
pyridyl)acetophenone5a and the synthesis of [NMeCHP]PF6 was 
achieved through extension of this existing chemistry (scheme 1). 
The initial 80:20 mixture of [NMeCHP]PF6 : [N
MeCHP]PF6 50 
was improved to > 9:1 after a single recrystallization from 
MeOH. The  was deduced from close inspection of pertinent 
resonances in the 1H NMR spectrum where all bar one of the 
methyl resonances, the bridgehead hydrogens and the methine 
hydrogens on the chiral carbon in the pyridyl arm of the two 55 
diastereomers are well separated. A small amount of analytically 
pure [NMeCHP]PF6 could be isolated upon repeated 
recrystallization but for the purposes of convenience, and to avoid 
the large compound loss associated with complete isomer 
separation, the majority of the coordination chemistry was 60 
performed with the 9:1  mixture of [NMeCHP]PF6 which, for 
simplicity, is abbreviated as [NMeCHP]PF6. 
 
Scheme 1. Synthesis of [NMeCHP]PF6. 
Copper(I), Silver(I) and Gold(I) complexes 65 
Tridentate coordination to Cu(I) was observed previously with 
the PCP’ ligand but aggregates predominated with the NCN’ 
ligand. Although the reasons for this disparate behaviour are not 
known precisely, the combination of a phosphine donor and a 
larger chelate in the PCP’ system was better able to support κ370 
coordination at pseudotetrahedral Cu(I). As NMeCP is a hybrid 
of the aforementioned NCN’ and PCP’ ligands it was of initial 
interest to know how it behaved upon coordination to Cu(I). The 
synthetic procedure was analogous to that used for the 
preparation of the [Cu(κ3PCP’)X] complexes with a 1:1 solution 75 
of [NMeCHP]PF6 and CuCl in THF being treated with 1.1 
equivalents of KHMDS. The resultant solution was examined 
 by 31P{1H} NMR spectroscopy which showed a number of 
phosphoruscontaining species suggesting a lack of coordination 
control of the NMeCP ligand and behavior more akin to that 80 
seen with NCN’ than PCP’. In an effort to better understand the 
coordination chemistry of NMeCP with Cu(I) it seemed 
expedient to prepare and characterize a precursor complex 
containing [NMeCHP]+, with the ideal precomplex having a 
[NMeCHP]PF6 : Cu(I) ratio of 1:1. However, the only pure 85 
compound isolated from 1:1 reaction mixtures with either CuX or 
[Cu(MeCN)4]
+ was the phosphinebound complex [Cu(κ	
NMeCHP)2(MeCN)2]BF4.(PF6)2, 1, which was prepared in high 
yield when the stoichiometry was increased to 2:1 in favor of the 
ligand. The 31P{1H} NMR spectrum of 1 showed a broadened 90 
peak (width at half height 43 Hz) at 7.1 ppm reflecting a 
coordination shift of around 10 ppm which is typical for Cu(I) 
phosphine complexation.8 The 1H NMR spectrum revealed an 
unchanged δH for the ortho hydrogen of the pyridine as expected 
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for an uncoordinated pyridine, and also confirmed the presence of 
a minor isomer which was not evident from the 31P{1H} NMR 
spectrum (this was presumably a complex containing the  form 
of the ligand). Examination of a THF solution of 1 after the 
addition of KHMDS by 31P{1H} NMR spectroscopy revealed the 5 
presence of a mixture very similar to that observed from the 
direct  reaction above except in this case there was clearly 
some free ligand generated as indicated by the sharp peak at δP = 
– 17 ppm. Attempts to isolate a pure compound from this mixture 
were unsuccessful and it was clear that the coordination 10 
chemistry of NMeCP with Cu(I) was neither simple nor 
appropriate for the formation of desired stereogenicatmetal 
complexes.  
The 1:1 complexation of Ag(I) with NCN’ and PCP’ mimicked 
that observed with Cu(I) in that numerous intractable species 15 
were observed with the former while a single species was isolated 
for the latter. The formation of a single species for the PCP’ 
ligand was partly assisted by the prior synthesis of a discrete, pre
complex of the amidinium precursor, namely [Ag(κ2PCHP’)2]
3+. 
This pathway was denied for the NCN’ donor as the related 20 
[Ag(κ2NCHN’)2]
3+ proved elusive. The success of the 
amidinium precomplex route for the PCP’ system prompted an 
initial focus on [NMeCHP]PF6 to see how the phosphine and/or 
pyridine donors coordinate to Ag(I) when the NHC anchor is 
unavailable. When a THF solution containing [NMeCHP]PF6 25 
and one equivalent of Ag(OTf) was stirred overnight a white 
solid (2.OTf) was deposited which was subsequently 
recrystallised from THF/Et2O at 4 °C as large colourless blocks 
(scheme 2). Identification of 2.OTf was aided by determination 
of the molecular structure by single crystal Xray techniques as 30 
shown in Figure 3. 
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Scheme 2. Synthesis of complexes 28. 
The complex is a headtotail dimer where each silver center is 35 
coordinated by a phosphine from one [NMeCHP]+ ligand and a 
pyridine from a second ligand so that the overall structure can be 
described as a 22membered disilver macrocycle. The dimeric 
structure is further supported by two bridging triflates each of 
which use separate oxygen atoms to coordinate to the two silver 40 
ions (for the purposes of clarity the CF3SO3
 groups are excluded 
from the figure). Each silver ion has a pseudotetrahedral 
geometry where the extent of the distortion from the tetrahedral 
ideal is exemplified by the intrametal bond angles that range 
from 67° to 141°. The AgP bond lengths of 2.367(3) and 45 
2.386(3) Å are shorter than the values of 2.441(2) and 2.464(2) Å 
reported for a related 8dppm complex9 but the AgN distances 
are similar. Closer correlation is observed with the complexes of 
Espinet10 where an average AgP bond length of 2.378(1) was 
reported along with AgN lengths of 2.334(4) Å and those of 2.39 50 
and 2.24 Å reported by Gimeno.11 Although the AgP and AgN 
bond lengths are similar for both parts of the dimer, it is not 
symmetric as the AgO bond lengths are quite disparate with 
values of 3.066(11) and 2.464(11) Å for one of the silver ions and 
2.776(11) and 2.538(11) Å for the other. The bridging triflates 55 
appear to be further supported by hydrogenbonding contacts 
between the RNC
NR hydrogens and selected oxygen atoms of 
the CF3SO3
 groups. The chiral carbon atoms in the pyridyl arms 
show the expected  stereochemistry and the two pyridine groups 
are mutually . 60 
 
 
Figure 3. The molecular structure of 2.OTf. Hydrogen atoms, lattice 
solvent, PF6
 counterions and bridging triflates (one of which sits above 
the Ag2P2N2 plane and the other below) are omitted for clarity. Selected 65 
bond lengths (Å) and angles (°): Ag1P2 2.367(3); Ag1N1 2.247(10); 
Ag2P1 2.386(3); Ag2N4 2.319(10); N1Ag1P2 140.5(3); N4Ag2P1 
138.1(3); N2C8N3 121.8(12); N5C43N6 123.2(12). 
The 31P{1H} NMR spectrum of 2.OTf consists of two doublets 
centered at 14.2 ppm for the two silver isotopomers with 1P70 
Ag(107) and 
1PAg(109) values of 650 and 751 Hz respectively. The 
chemical shift is downfield of the 31P{1H} resonance for 
[NMeCHP]PF6 and the observation of PAg coupling is indicative 
of slow phosphine exchange at room temperature. The magnitude 
of the coupling constants suggests two coordinate, presumably 75 
linear, Ag(I) indicating loss of the weakly bound bridging triflates 
upon dissolution.12 The pyridine groups remain coordinated as 
evidenced by the downfield shifted (8.95 ppm)  proton 
resonance in the 1H NMR spectrum which is better resolved for 
the mixed PF6
/BF4
 salt as some broadening is evident with the 80 
PF6
/CF3SO3
 compound (see supplementary material). The 
13C{1H} NMR spectrum is fully consistent with these conclusions 
but only monomeric species were observed in the HRMS. 
When the reaction of [NMeCHP]PF6 with AgOTf was repeated 
in a 2:1 L:M ratio the 31P{1H} NMR spectrum of the reaction 85 
mixture in THF showed a broad doublet at ~ 5 ppm. Removal of 
the solvent gave a white solid, [Ag(κ	NMeCHP)2]OTf.(PF6)2, 3, 
that was sparingly soluble in CHCl3 and MeCN but more soluble 
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in acetone and dichloromethane. The 1H NMR spectrum recorded 
in CD2Cl2 was similar to the uncoordinated ligand with the 
amidinium hydrogen being very evident as a singlet at δH = 8.06 
ppm. It is noteworthy that the position of the pyridine 
hydrogen(s) is little shifted from its position in the spectrum of 5 
[NMeCHP]PF6 and it would appear that the coordination of the 
pyridine donors is transient or completely absent in 3. 
When 2.OTf was treated with a slight excess of KHMDS in THF 
the 31P{1H} NMR spectrum changed from the pair of doublets at 
14.2 ppm for 2.OTf to a new pair of doublets centered at 3.40 10 
ppm. The reaction was clean by 31P{1H} NMR spectroscopy as 
no other phosphorus containing species were detected in solution 
and, after workup, complex 4 was isolated as feathery crystals. 
Although spectroscopically pure (see below) the crystals were not 
of sufficient quality to allow the determination of the solidstate 15 
structure by singlecrystal Xray diffraction and it was unclear, at 
this stage, whether the compound was a monomer or a dimer. The 
two doublets in the 31P{1H} NMR spectrum had 1PAg coupling 
constants of 467 and 539 Hz for 107Ag and 109Ag respectively, 
appreciably smaller than those observed for 2.OTf which may 20 
reflect a coordination number >2 or simply be a consequence of 
the different nature of the donor  to the phosphine (ERNHC 
vs pyridine). The magnitude of the 1PAg coupling constants 
compare with related, welldefined, linear 2coordinate 
complexes containing phosphines  to NHCs which supports 25 
the notion of twocoordinate silver in solution.13 This relative 
orientation of donors is not possible for a monomeric complex 
containing κ2 or κ3NMeCP and it would appear that the CNHC 
donor has replaced the pyridine upon addition of base to give 
dimeric [Ag2(8	N
MeCP)2](PF6)2. The lack of a coordinated 30 
pyridine is supported by the position of the  pyridine 
resonance in the 1H NMR spectrum of 4 where it is observed 
close to its position in the spectrum of the uncoordinated 
[NMeCHP]PF6 proligand. Comparison of the 
1H NMR spectrum 
of 4 with 2.OTf reveals further distinctions, notably the absence 35 
of the characteristic singlet for the amidinium hydrogen and a 
significant downfield shift of ≥ 1 ppm for one of the methylene 
hydrogens in the phosphine arm. The NHC carbon appears as a 
doublet of doublets at 208.7 ppm for each Ag isotopomer in the 
13C{1H} NMR spectrum with coupling constants of 195, 224 and 40 
54 Hz for 1CAg(107), 
1CAg(109) and 
2CP respectively. The 
observation of the latter coupling confirms that each silver ion is 
coordinated by an NHC and a phosphorus donor and the fact that 
all three coupling constants have values that closely mimic those 
for a related linear [Ag(phosphine)(NHC)]+ complex (δC = 200.5 45 
ppm, 1CAg(107), 
1CAg(109), 
2CP = 199.5, 233.2, 64.6 Hz)
13 does 
suggest that 4 is the headtotail [Ag2(8	N
MeCP)2](PF6)2 
dimer. The observed chemical shift and the magnitude of the Ag
CNHC coupling constants also accord with data reported 
previously for 6/7membered ERNHC complexes14 although 50 
further comparison with closely analogous systems with a 
carbene donor  to a phosphine is limited by the scarcity of 
such compounds. Other than the aforementioned complexes of 
Tapu,13 2CP data for similar compounds is lacking due to poor 
solubility,15 complicating secondary couplings or the complete 55 
absence of an observed signal and/or CP coupling.16 Hofmann 
has observed a 2C,P value of 76.7 Hz for a related Cu(I) dimer.
17 
Unfortunately, although species of molecular mass > 1250 were 
observed by mass spectrometry, formulations for these proved 
elusive and consequently high resolution data is only available 60 
for monomeric fragmentation species (see experimental). While 
the absence of qualifying crystallographic and/or mass 
spectrometric data prevents an unequivocal assignment of the 
molecular structure, the spectroscopic data does provide strong 
circumstantial evidence for the HT dimer which is further 65 
supported by structural determination of the analogous digold 
complex (see below). 
Unlike Ag(I) the coordination chemistry of gold(I) is dominated 
by the 2coordinate linear geometry and it was anticipated that 
the Au(I) complexes of both [NMeCHP]+ and NMeCP would 70 
subscribe to this preference. This proclivity is not conducive to 
the formation of stereogenicatmetal complexes but can be 
useful for the construction of multimetallic systems as κ1
coordination at gold frees up the remaining donors for 
coordination to other metals. The 1:1 reaction of [NMeCHP]PF6 75 
with Au(THT)Cl gave, after workup, a white solid (5) with a 
31P{1H} NMR spectrum that consisted of one major (~90%) and 
one minor (~10%) peak at 25.0 and 24.8 ppm respectively for the 
two possible isomers resulting from the 9:1 diastereomeric 
composition of the ligand. The 1H NMR spectrum is 80 
unremarkable and resembles quite closely the spectrum of 
[NMeCHP]PF6 suggesting an unbound pyridine group and a 
formulation of [Au(κ	NMeCHP)Cl]PF6. Likewise the 
13C{1H} 
NMR is predictable as might be expected for the simple 
coordination of the Pdonor and the formulation is confirmed by 85 
HRMS where a peak at 764.2230 amu is observed. When the 
reaction was performed with a 2:1 ratio of [NMeCHP]PF6 to 
Au(I) a white solid [Au(κ	NMeCHP)2]Cl.(PF6)2 (6) was isolated 
which gave two broad singlets for the major and minor isomers at 
9.6 and 10.7 ppm in the 31P{1H} NMR spectrum. The upfield 90 
shift of the 31P{1H} resonance for both isomers compared to those 
of 5 is commensurate with that expected upon replacement of a 
chloride ligand  to the phosphine by a second phosphine and 
the broadening is likely the result of some restricted rotation 
about the AuP bonds or a relatively slow, undiscerned fluxional 95 
process. The 1H NMR spectrum of the diastereomeric mixture 
confirmed the presence of the amidinium hydrogen at δH = 8.7 
ppm but was otherwise of little diagnostic value. The formulation 
was confirmed by mass spectrometry where a peak at m/z = 
1441.4806 for the complex trication plus one PF6
 and one Cl 100 
was observed. 
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Figure 4. The molecular structure of 
[Au2(8	N
MeCP)2](PF6)2, 7. 
Hydrogen atoms, lattice solvent and PF6
 counterions are omitted for 
clarity. Selected bond lengths (Å) and angles (°): Au1P1 2.296(5); Au1
C19 2.108(17); Au2P2 2.281(6); Au2C54 2.091(17); P1Au1C19 5 
171.6(5); P2Au2C54 171.0(6); N1C19N2 120.1(15); N3C54N4 
120.2(16). 
Transmetallation of 
[Ag2(8	N
MeCP)2](PF6)2 with two 
equivalents of Au(THT)Cl gave the analogous bimetallic gold 
complex 
[Au2(8	N
MeCP)2](PF6)2, 7, the structure of 10 
which was confirmed by singlecrystal Xray diffraction (Figure 
4). The complex could also be prepared by prior   
deprotonation of [NMeCHP]+ and subsequent addition of the 
gold starting complex or from complex 5 upon addition of base. 
The molecular structure, shown in figure 4, is a headtotail dimer 15 
where the two gold ions are coordinated to one NHC and one 
phosphine donor from the two bridging NMeCP ligands 
respectively. The geometry at the metal is linear two coordinate 
as expected with a slightly acute average PAuC bond angle of 
171.3° and a distance of 4.871 Å between the two gold atoms. 20 
The AuP and AuC bond lengths of 2.281(6), 2.296(5) and 
2.091(17), 2.108(17) Å respectively, largely align with those 
reported for related complexes although the latter are towards the 
longer end of the reported range.16,18 The NCN angle of the 
carbene unit averages 120.2° which is towards the upper end of 25 
the range for 6/7membered ERNHCs.18c,d The overall structure 
of the digold macrocycle is puckered with the two PAuC 
vectors orientated at an angle of ~63° to one another. Such an 
orientation results in (or is possibly the result of) aromatic 
stacking of the two phenyl rings fused to the 14membered 30 
macrocyclic ring although the distance between the centroids of 
each ring is relatively long at 4.228 Å. Of the two possible 
conformations, δ and λ, defined by the relation of the two PAuC 
vectors, only the δ form occurs in the solidstate. Although the 
structure shown in figure 4 is of a rare type, 
 gold dimers of 35 
phosphineNHC heterotopic ligands are known for systems where 
the P donor is directly connected to one or both of the nitrogens 
of the NHC.6i,16 Symmetrically substituted 
(diphenylphosphinoethyl)NHCs do form gold trimers but the 
coordination at each of the gold atoms is through solely 40 
phosphine or carbene donors.6i  
When [Au(κ	NMeCHP)2]Cl.(PF6)2 (generated in situ in THF) 
was treated with 2.2 equivalents of KHMDS the peak in the 
31P{1H} NMR spectrum for the major diastereomer changed from 
a broad singlet (width at half height 78 Hz) at δP ~10 ppm to a 45 
slightly broadened singlet (width at half height 24 Hz) at δP = 
17.0 ppm. The similarity between this latter chemical shift and 
that of [NMeCHP]+ indicates that the phosphines have been 
displaced by the NHC donors upon deprotonation of the 
amidinium groups to generate [Au(κNMeCP)2]PF6, 8. Dangling 50 
phosphines have been observed previously in related Ag(I) 
systems.19 The 1H NMR spectrum of the complex lacks the 
amidinium hydrogen as expected and shows some broadening 
particularly for the C
2(C6H4)PPh2 methylene resonances which 
may reflect some restricted rotation about the AuC or NC/CCAr 55 
bond or possible transient coordination of the phosphine donors 
(accepting that the 31P NMR spectrum indicates a predominantly 
unbound state). Coordination of the carbenic carbon is confirmed 
on inspection of the 13C{1H} NMR spectrum which shows a 
signal at δC 202.8 ppm for these carbons, which is a similar 60 
position to the chemical shifts reported for analogous ERNHC 
complexes of Au(I).16,18 
The molecular structure of 8 shows the gold bound to two 
NMeCP ligands solely through the NHC carbons to produce the 
expected linear complex (Figure 5). As deduced from the NMR 65 
measurements the phosphine and pyridine donors play no part in 
the coordination and each is arranged mutually  to the like 
donor of the other ligand in the solidstate. The CAuC bond 
angle is close to linear at 175.0(6)° and the AuC bond lengths 
are very typical for NHC complexes of this type. There is 70 
some disparity in the NCN bond angles where one, at 118.6(9)°, 
is typical of an ERNHC, but the other is somewhat compressed 
at 115.4(10)°. The two NCN planes are canted with respect to one 
another with a relatively small skew angle of ~ 23°. The 
uncoordinated phosphine and pyridine donors are available for 75 
binding to other metal ions to make heterometallic dimers and 
trimers as is being investigated currently in our laboratories. 
 
Figure 5. The molecular structure of [Au(κNMeCP}2]PF6, 8. Hydrogen 
atoms, lattice solvent and PF6
 counterions are omitted for clarity. 80 
Selected bond lengths (Å) and angles (°): Au1C20 2.029(12); Au1C55 
2.071(10); C20Au1C55 175.0(6); N1C20N2 115.4(10); N4C55N5 
118.6(9). 
Nickel(II), Platinum(II) and Rhodium(I) complexes 
The failure to acquire any κ2 or κ3 complexes of the monovalent 85 
group 11 metals prompted an inspection of other metal ions 
where such modes are expected. Ni(II), Pd(II), Pt(II) and Rh(I) 
formed κ3complexes with one or other or both of the previously 
reported NCN’ and PCP’ ligands and were thus chosen as good 
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candidates for the formation of complexes of the type [M(κ3
NMeCP)X]n+. Although the resultant square planar complexes 
would be neither labile (with the possible exception of Ni2+) nor 
stereogenicatmetal, they did provide an opportunity to 
investigate any conformational preference of the fully chelated 5 
ligand in the absence of configurational complications. It is well 
known that NHCs coordinate with a preference for the NCN 
plane to lie at an angle to the coordination plane, . in square 
planar complexes of Pt(II), Rh(I) etc, it is typically canted at an 
angle of ~50° to the square ML4 plane. For unsymmetrically 10 
substituted NHCs, the drop (conformation) can then be described 
as δ or λ depending upon the relative orientation of the two 
planes.20 There is usually little to no conformational selectivity 
observed for monodentate NHCs but overall ligand 
conformations of δ and/or λ can be adopted in complexes of 15 
tridentate ligands with central NHC donors. Part of the remit of 
our study is to examine conformational selectivity in certain 
complexes of κ3NMeCP and to attempt to understand what 
factors, other than preferential NHC binding, influence the δ/λ 
isomer distribution.  20 
When a 1:1 mixture of [NMeCHP]PF6 and Ni(COD)2 in THF 
was monitored by 31P{1H} spectroscopy, a gradual loss of signal 
for the proligand (δP = 16.2 ppm) was observed commensurate 
with the growth of a new resonance at δP = 13.1 ppm. After 
approximately 24 hours only the signal at 13.1 ppm remained. 25 
The resultant complex, [Ni(κ3NMeCP)(η3C8H13)]PF6, 9, was 
isolated as an orangeyellow solid upon removal of all volatiles. 
The 1H NMR spectrum of 9 showed resonances at 5.22 (t, 3HH = 
8.5 Hz), 4.36 (m) and 3.91 (m) ppm characteristic of the 
formation of the η3cyclooctenyl ligand concordant with the 30 
structural assignment of [Ni(κ3NMeCP)(η3C8H13)]PF6. This is 
analogous to the reactivity observed previously with 
[NCHN’]PF6.
5 The coordination of both the NHC carbon and the 
phosphine was confirmed by 13C{1H} NMR spectroscopy where 
the carbenic carbon was observed as a doublet (2CP = 16.5 Hz) at 35 
202.1 ppm. This compares with a shift of 189.3 ppm and a 2CP 
of 32 Hz in the related PCP pincer complex of Fryzuk8e and 162.8 
ppm (2CP = 35.5 Hz) for a [Ni(P^NHC)2] complex;
21 it 
should be noted that both of these reported ligands contain 
normal 5membered NHCs. The 1H NMR spectrum of 9 also 40 
shows a high field doublet for the methyl group attached to the 
chiral carbon of the pyridyl arm at 0.33 ppm. This is shifted 1.2 
ppm upfield of its position in the spectrum of [NMeCHP]PF6 
and is reminiscent of the chemical shift of the analogous methyl 
group in the 5coordinate complexes of the type [M(κ345 
NCN’)(C8H12)]
+ (M = Rh, Ir). The shift likely results from the 
CH3 group residing in the shielding region of an aromatic ring but 
attempts to confirm this by single crystal Xray diffraction were 
unsuccessful. Although two isomers of [Ni(κ3NCN’)(η3C8H13)]
+ 
were produced, this does not appear to be the case for 9 as only a 50 
single peak is observed at δP = 13.1 ppm in the 
31P{1H} spectrum. 
There is evidence of a second species in the 1H NMR spectrum 
but the majority of the sample (>90%) is a single isomer and the 
minor isomer is likely to be the complex from the coordination of 
the small amount of NMeCP present. The large chemical shift 55 
difference between the two methylene protons of the phosphine 
arm is characteristic of the formation of the P^C chelate which is 
confirmed upon inspection of the 13C{1H} NMR spectrum where 
a peak at δC = 202.1 (
2CP = 16.5 Hz) for the carbenic carbon is 
observed. Although the structure of 9 cannot be confirmed 60 
unequivocally, a geometry grossly similar to [Ni(κ3NCN’)(η3
C8H13)]
+ with an axial pyridine and the phosphine in the pseudo
equatorial plane is most likely. 
 
 65 
Scheme 3. Synthesis of complexes 914. i) Ni(1,5COD)2, THF, RT, 24 
hrs; ii) CHCl3, air; iii) 0.5 K2[PtCl4], EtOH, X, 18 hrs; iv) 2 KHMDS, 
THF; v) 0.5 [Rh(acac)CO]2, THF, RT; vi) PhCl, 120 °, 2 hrs. 
Exposure of a CHCl3 solution of 9 to air gave, after several hours, 
a solution containing two peaks in the 31P{1H} NMR spectrum at 70 
8.0 and 5.2 ppm. After filtering off a slight gelatinous precipitate 
the compound could be crystallized in low yield from MeOH. 
The structure of the complex determined by singlecrystal xray 
techniques is shown in figure 6. It is clear from the figure that the 
allyl ligand has been lost and the metal has acquired a chloride in 75 
an analogous manner to that already observed for [Ni(κ3
NCN’)(η3C8H13)]
+.5c The nickel centre is square planar with four 
different donors defining the corners of the plane. The 
asymmetric unit of the solidstate structure contains two 
independent molecules which are conformational isomers (δ and 80 
λ). There are a number of metric differences between the two 
conformers including an expanded NNiP bond angle of 176.9° 
in the δ form compared to 170.1° for the λ which mainly results 
from the larger CNiP angle in the former (92.53° vs 87.57°). 
There is no such discrepancy in the NNiC angles which are 85 
86.54±0.04°. The sixmembered NNiC ring has a boat 
conformation in both isomers and the stereochemistry of the 
chiral carbon in the pyridyl arm is the anticipated . Somewhat 
surprisingly the orientation of the methyl group attached to the 
stereogenic carbon in the NNiC4 ring is different for each 90 
isomer with an axial projection being seen in the δ conformer and 
equatorial in the λ as highlighted in figure 6. There are several 
other structural differences between the two conformers, notably 
the orientation of one of the methyl groups of the 
dimethylmethylene bridge which approaches a phosphorusbound 95 
phenyl in the δ isomer but projects towards the pyridine group in 
the λ conformer. The NiL bond lengths are largely invariant 
between the two forms and are within the ranges expected for a 
square planar Ni(II) complex of this type. 
 100 
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Figure 6. The molecular structure of one (δ) of the two conformers of 
[Ni(κ3	NCP)Cl]+, 10 (upper view) and the orientation of the ligand 5 
backbone in the two conformers, δ (middle) and λ (lower). Hydrogen 
atoms, lattice solvent and PF6
 counterions are omitted for clarity. 
Selected bond lengths (Å) and angles (°): Ni2C63 1.895(7); Ni2P2 
2.2242(18); Ni2N6 1.940(6); C63Ni2P2 92.53(19); C63Ni2N6 
86.5(3); P2Ni2Cl2 91.36(8); N6Ni2Cl2 89.62(19); N4C63N5 10 
118.2(6). 
The low isolated yield of this complex is largely due to its 
decomposition in solution. Repeated efforts to improve the yield 
were unsuccessful with only small amounts of crystalline material 
being acquired from any given synthesis. The 31P{1H} spectrum 15 
of the complex recorded immediately after dissolution in normal 
aerated CD3OD showed the two peaks noted above in ratios that 
varied from 1:1 to 1:3 from batch to batch. The 1H NMR 
spectrum was also complicated by the presence of duplicate 
signals for the isomeric mixture. After a short period of time the 20 
spectra started to show the presence of another complex which, 
within a matter of hours, was the sole species present in solution. 
This decomposition product was defined by a single peak at δP 32 
ppm in the 31P{1H} spectrum which is characteristic of an 
oxidized phosphine group and it appeared that the phosphine 25 
donor in 10 is hemilabile allowing competitive oxidation on 
phosphine release. This suggests a relatively large degree of 
strain in the sevenmembered chelate which appears to destabilize 
the nickel complex. The poor yield of the complex coupled with 
its instability in solution prevented acquisition of a 13C NMR 30 
spectrum for 10. 
The isolation of 10 as a mixture of two conformers showed a lack 
of conformational control akin to that observed for [Ni(κ3
NCN’)Cl]+. This was surprising as only a single isomer was seen 
for the precursor cyclooctenyl complex 9, and inclusion of the 35 
additional chiral centre in the pyridyl chelate had previously led 
to complete coordination control albeit in fivecoordinate 
Rh(I)/Ir(I) systems.5a Irrespective of the unstable nature of 10 in 
aerated solution, the fact that two conformational isomers were 
observed does suggest that the current ligand system is poorly 40 
selective for square planar Ni(II). In an effort to establish whether 
this was a general trend or simply the result of the nature of the 
conversion of 9 to 10 and/or the binding sequence upon addition 
of NMeCP to Ni(dme)Cl2, we sought to examine other systems 
of the type [M(κ3	NMeCP)L]+ (M = Pt, Rh). The preferred 45 
route to the platinum complex was through initial P,N
coordination of [NMeNCHP]PF6 to give [Pt(κ
2	
NMeCHP)Cl2]PF6 followed by treatment with base to promote κ
3 
coordination. However when [NMeCHP]PF6 was reacted with 
K2[PtCl4] or [Pt(COD)Cl2] in a 1:1 ratio, the only complex 50 
isolated was [Pt(κ	NMeNCHP)2Cl2](PF6)2 (11); the yield 
of which was improved, as expected, upon repeating the reactions 
with a 2:1 L:M ratio. The structure of the complex was confirmed 
as  upon analysis by singlecrystal Xray crystallography 
(figure 7). 55 
 
Figure 7. The molecular structure of [Pt(κ	NMeCHP)2Cl2](PF6)2, 
11. Hydrogen atoms, lattice solvent and PF6
 counterions are omitted for 
clarity. Selected bond lengths (Å) and angles (°): Pt1P1 2.3068(17); Pt1
P2 2.3102(17); Pt1Cl1 2.3026(19); Pt1Cl2 2.2983(19), P1Pt1Cl1 60 
93.15(7); P1Pt1Cl2 86.68(7); P2Pt1Cl1 86.73(7); P2Pt1Cl2 
93.46(7); P1Pt1P2 179.09(17). 
Addition of 1.1 equivalents of KHMDS to [Pt(κ	
NMeCHP)2Cl2](PF6)2 in THF gave, upon leaving open on the 
bench for several days, large crystals of the complex [Pt(κ365 
	NMeCP)Cl]PF6, 12, the molecular structure of which is 
shown in figure 8. Unlike the Ni(II) analog, 12 crystallises as a 
single isomer with an overall ligand conformation of δ. All other 
gross structural features are closely analogous to those already 
described for the δ conformer of 10. The 31P{1H} NMR spectrum 70 
of 12 consists of a singlet at δP 7.8 ppm with platinum satellites 
(1PPt = 3655 Hz). The chemical shift is > 20 ppm upfield of its 
position in 11 but this is not unexpected for the formation of a 
sevenmembered chelate and the onebond metalphosphorus 
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coupling constant is typical.22 The observation of a single species 
in the solidstate extends to the solution as relatively simple NMR 
spectra are observed for compound 12. It is likely that the δ 
conformer observed in the solidstate persists in solution as there 
is no evidence for rapid δ↔λ exchange as the complex shows 5 
temperature invariant 31P and 1H NMR spectra over the 200
350K range. Complex 12 could also be prepared by 
transmetallation using 4 and 2 equivalents of Pt(COD)Cl2 or 
through direct coordination of  generated NMeCP with the 
same platinum precursor in a 1:1 ratio, however the products 10 
from these approaches were more difficult to purify than the 
synthesis using 11.  
 
Figure 8. The molecular structure of [Pt(κ3	NMeCP)Cl]+, 12. 
Hydrogen atoms, lattice solvent and PF6
 counterions are omitted for 15 
clarity. Selected bond lengths (Å) and angles (°): Pt1C8 1.991(5); Pt1P1 
2.2579(15); Pt1N1 2.072(5); Pt1Cl1 2.3471(15), P1Pt1C8 92.84(15); 
N1Pt1C8 86.1(2); P1Pt1Cl1 93.85(6); N1Pt1Cl1 87.12(14); N2C8
N3 118.6(5). 
The Ni(II) and Pt(II) complexes above showed completely 20 
disparate behavior so that ambiguity surrounded the ability of 
NMeCP to bind stereoselectively to square planar complexes. In 
an effort to increase our understanding of this conformational 
complexity, we sought to prepare [Rh(κ3	
NMeNCP)(CO)]PF6, 14, as a further example. The complex 25 
[Rh(κ	NMeCHP)(acac)(CO)]PF6, 13, was chosen as the 
precursor to 14 as it presented an internal base (acac) capable of 
an intramolecular deprotonation of the pendant amidinium group 
that is predisposed for coordination of the carbene upon its 
release. Addition of solid [NMeCHP]PF6 to a solution of 30 
[Rh(acac)(CO)2] in THF at room temperature gave immediate 
effervescence suggesting rapid replacement of one CO group by 
the phosphine donor. This was confirmed upon inspection of the 
31P{1H} NMR spectrum of the reaction mixture which consisted 
of a doublet (1PRh = 170.4 Hz) at 43.3 ppm consistent with the 35 
formation of complex 13. Removal of volatiles gave an orange
yellow solid which showed the presence of the amidinium 
hydrogen at 7.88 ppm in the 1H NMR spectrum in addition to a 
largely unshifted orthopyridine proton resonance at 8.46 ppm 
reflecting the lack of pyridine coordination. Heating a solution of 40 
13 to 140 ⁰C in chlorobenzene over a period of 2 hours led to the 
disappearance of the signal for 13 in the 31P{1H} NMR spectrum 
commensurate with the appearance of two new doublets at δ = 
28.8 (1PRh = 166 Hz, minor) and 27.1 (
1PRh = 165 Hz, major) 
ppm respectively for the two isomeric forms of complex 14. The 45 
presence of the two isomers in a roughly 1:3 ratio indicated a 
degree of selectivity during the change from κ1	 to κ3	 
coordination but this is far from absolute. The upfield shift in δP 
compared to 13 is indicative of the change in coordination mode 
from monodentate to tridentate as observed in the platinum 50 
complexes. Attempts to form crystals of the complex suitable for 
structural characterization by singlecrystal xray techniques were 
thwarted by the solution instability of the complex. Although the 
ultimate fate of the compound was not determined, 14 appears to 
undergo a similar κ3 to κ2 conversion to that described for 10. 55 
This conversion led to very poor yields of pure complex being 
obtained (as essentially 1:1 isomeric mixtures) and hence the 13C 
NMR spectrum given in the SI is for the crude reaction product 
before attempted purification. 
Conclusions 60 
The coordination chemistry of an asymmetric, potentially 
bidentate N,P donor with a central amidinium core (
[NMeCHP]+) and its deprotonated, tridentate NpyCNHCP derivative, 
NMeCP, has been explored with selected group 9, 10 and 11 
metal ions. The chemistry with the monovalent group 11 metal 65 
ions is dominated by bridged species with the formation of head
totail dimers through 8	 and 8	 binding using 
[NMeCHP]+ and NMeCP, respectively. The isolation of such 
species points to reduced chelate stability in these complexes. 
This did not extend to Ni(II), Pt(II) and Rh(I) systems where κ370 
coordinated complexes of NMeCP were readily formed and 
isolated. Although both [Pt(κ3	NMeCP)Cl]+ and [Rh(κ3
	NMeCP)(CO)]+ were prepared from precursors containing 
[κ	NMeCHP]+, only the former showed conformational 
selectivity upon establishment of tridentate coordination. The 75 
related [Ni(κ3 	NMeCP)Cl]+ was accessed by a different 
route and showed little conformational preference. Although it is 
evident that NMeCP is a flexible ligand able to accommodate 
metal ions that desire chelating modes as well as those that tend 
to form bimetallic (and higher) species, it remains unclear what 80 
conditions are required to promote conformational (and 
ultimately configurational) control in chelated forms. We are 
currently working to further understand these factors and are 
seeking to extend the bridged chemistry towards the controlled 
formation of mixed metal complexes. 85 
Experimental 
General information: All synthetic procedures and 
manipulations were performed under dry nitrogen using standard 
Schlenk line techniques. Solvents were freshly distilled from 
sodium (toluene), sodium/benzophenone (THF) or calcium 90 
hydride (acetonitrile, methanol and dichloromethane) under 
nitrogen before use. All other chemicals were obtained 
commercially and used as received.  The 
31P{1H}, 1H and 13C 
NMR spectra were recorded on a Jeol Eclipse 300 MHz or 
Bruker Avance 400, 500 or 600 MHz spectrometers and 95 
referenced to tetramethylsilane or H3PO4(δ = 0 ppm).  Mass 
spectra were obtained using a Waters LCT Premier XE mass 
spectrometer or at the EPSRC UK National Mass Spectrometry 
Facility at Swansea University. 
Crystallography 100 
Page 8 of 15Dalton Transactions
Da
lto
nT
ran
sa
cti
on
sA
cc
ep
ted
Ma
nu
sc
rip
t
Pu
bl
ish
ed
 o
n 
18
 Ju
ly
 2
01
6.
 D
ow
nl
oa
de
d 
by
 C
ar
di
ff 
U
ni
ve
rs
ity
 L
ib
ra
rie
s o
n 
18
/0
7/
20
16
 1
7:
36
:3
5.
 
View Article Online
DOI: 10.1039/C6DT02476A
 !" #$%&' 
(&'(()* 
Singlecrystal XRD data for compounds 2, 7, 8, 11 and 12 were 
collected on an Agilent SuperNova Dual Atlas diffractometer 
with a mirror monochromator [using either Cu (λ = 1.5418 Å) or 
Mo (λ = 0.7107 Å) radiation], equipped with an Oxford 
Cryosystems cooling apparatus. Generally, the crystal structures 5 
were solved and refined using SHELX.23 Nonhydrogen atoms 
were refined with anisotropic displacement parameters. Hydrogen 
atoms were inserted in idealized positions, and a riding model 
was used with Uiso set at 1.2 or 1.5 times the value of Ueq for the 
atom to which they are bonded. Data collection and structure 10 
solution for compound 10 were performed at the EPSRC National 
Crystallography Service as detailed.24 Further details and the 
relevant CIF files for all structurally characterized complexes are 
included in the SI. 
Syntheses 15 
[NMeCHP]PF6. 
A solution of 1,31,2,2trimethyl1,3diaminocyclopentane, 
tmcp  (1.00 g, 7 mmol), and 2acetylpyridine (0.85 g, 1 mol 
equiv) in EtOH (50 ml) was heated close to boiling for 4 hrs. 
After cooling, the solvent was removed on a rotary evaporator 20 
and the residue redissolved in EtOH (50 ml). To this solution was 
added solid NaBH4 (0.40 g, 10.5 mmol) portionwise over 20 
mins. The resulting mixture was stirred overnight before adding 
conc. HCl (1 ml) carefully with stirring. After stirring for a 
further 30 mins the volatiles were removed in , the residue 25 
dissolved in water (50 ml) and the mixture made strongly basic 
by addition of solid NaOH. The diamine that oiled out of solution 
was extracted into CH2Cl2 (3 x 50 ml), which was subsequently 
dried over MgSO4, filtered and all volatiles removed in  to 
give the monopyridyl diamine as a pale yellow oil. 1H NMR 30 
analysis of this intermediate showed it to be a mixture of two 
isomers in a 3.5:1 ratio. The oil was dissolved in degassed EtOH 
(50 ml) under nitrogen and 2
(diphenylphosphino)carboxaldehyde (2.03 g, 7 mmol) added 
thereto. The solution was heated close to boiling for 12 hrs before 35 
cooling and removing the solvent in . The residue was 
dissolved in EtOH (50 ml) and solid NaBH4 (0.40 g, 10.5 mmol) 
added portionwise over 20 mins. The resulting mixture was 
stirred overnight then conc. HCl (1 ml) added carefully with 
stirring. After stirring for a further 30 mins the volatiles were 40 
removed in , the residue dissolved in water (50 ml) and the 
mixture made strongly basic by addition of solid NaOH. The 
product that oiled out of solution was extracted into CH2Cl2 (3 x 
50 ml), which was subsequently dried over MgSO4, filtered and 
all volatiles removed in  to give a pale yellow oil. The oil 45 
was taken into triethylorthoformate (15 ml), NH4PF6 (1.26 g, 1.1 
equivs) added and the mixture heated at 120 °C for 2 hrs 
whereupon a white solid deposited. After standing overnight the 
mixture was filtered and the solid washed carefully with MeOH. 
Yield = 2.56 g (54%). A pure sample of the isomer could be 50 
obtained by recrystallization from MeOH, however, this was 
accompanied by appreciable loss of material so the complexation 
chemistry was performed with the original 9:1 : mixture. The 
compound is airstable in the solidstate but was kept under N2 as 
a precaution. The following spectroscopic details are for the  55 
isomer. 1H NMR (CDCl3, 400 MHz) δ 8.42 (d,  4.4 Hz, 1H), 
7.81 (s, 1H), 7.67 (dt,  7.7, 1.8 Hz, 1H), 7.457.05 (m, 15H), 
6.89 (dd,  7.4, 4.4 Hz, 1H), 4.84 (q,  6.9 Hz, 1H), 4.71 (m, 2H), 
3.74 (d,  5.1 Hz, 1H), 2.42 (m, 1H), 2.04 (m, 1H), 1.90 (m, 1H), 
1.78 (m, 1H), 1.56 (d,  7.0 Hz, 3H), 1.18 (s, 3H), 0.96 (s, 3H), 60 
0.54 (s, 3H) ppm.  13C{1H} NMR (CD2Cl2, 100 MHz) δ 156.2 
(C), 152.2 (d,  2.6 Hz, CH), 149.8 (CH), 137.0 (d,  5.5 Hz, C), 
136.8 (d,  3.6 Hz, C), 135.0 (d,  2.5 Hz, C), 134.9 (d,  2.7 Hz, 
C), 133.9 (d,  9.7 Hz, CH), 133.7 (d,  9.5 Hz, CH), 130.3 (d,  
4.6 Hz, CH), 130.1 (CH), 129.7 (CH), 129.5 (d,  9.2 Hz, CH), 65 
129.0 (d,  2.8 Hz, CH), 128.9 (d,  2.4 Hz, CH), 124.0 (CH), 
122.4 (CH), 72.4 (C), 66.1 (CH), 63.9 (CH), 51.7 (CH2, d,  25.9 
Hz), 40.9 (C), 39.8 (CH2), 32.1 (CH2), 21.2 (CH3), 18.3 (CH3), 
16.7 (CH3), 14.4 (CH3) ppm.  HRMS (ES):   532.2880 (calc. 
532.2882) [L – PF6]
+, 100%. Anal. Calcd for C35H39N3P2F6: C, 70 
62.02; H, 5.81; N, 6.20. Found: C, 61.9; H, 5.8; N, 6.3. 
[Cu(κNMeCHP)2(MeCN)2]BF4.(PF6)2, 1 
A solution of [NMeCHP]PF6 (100 mg, 0.15 mmol) and 
[Cu(MeCN)4]BF4 (24 mg, 0.075 mmol) in THF (5 mL) was 
stirred at RT overnight and the volatiles subsequently removed in 75 
 to give a white solid that was dissolved in CH2Cl2, filtered 
and taken to dryness to give 1 as a white solid. Yield: 80 mg, 
68%. 1H NMR (500 MHz, CD2Cl2) δ (major isomer) 8.54 (d,  
4.2 Hz, 2H), 7.84 (s, 2H), 7.73 (dt,  7.4, 1.6 Hz, 2H), 7.52 (t,  
7.4 Hz, 2H), 7.45 – 7.05 (m, 30H), 4.86 (q,  6.9 Hz, 2H), 4.75 80 
(d,  16.7 Hz, 2H), 4.61 (d,  16.7 Hz, 2H), 3.35 (d,  4.8 Hz, 
2H), 2.01 (m, 6H), 1.63 (d,  6.9 Hz, 6H), 1.49 (m, 2H), 0.81 (s, 
6H), 0.79 (s, 6H), 0.43 (s, 6H), ppm. 13C{1H} NMR (CD2Cl2, 
125.8 MHz) δ 155.4 (C), 154.1 (CH), 148.9 (CH), 138.0  122.1 
(20 x aromatics), 71.4 (C), 63.4 (CH), 63.2 (CH), 50.9 (d,  14.1 85 
Hz, CH2), 40.2 (C), 38.7 (CH2), 31.3 (CH2), 20.5 (CH3), 16.2 
(CH3), 15.9 (CH3), 13.0 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, 
CD2Cl2) δ 7.1 (br) ppm. HRMS (ES):   1417.4324 (calc. 
1417.4343) [M + 2PF6  2MeCN]
+, 100%. Unfortunately, despite 
multiple attempts, acceptable analytical data could not be 90 
obtained for this complex. Analyses were consistently low in 
carbon and, to some extent, nitrogen which may relate to MeCN 
loss prior to combustion. 
[Ag2(AN
MeCHP)2(AO3SCF3)2](PF6)2, 2.OTf 
A solution of [NMeCHP]PF6 (100 mg, 0.15 mmol) and AgOTf 95 
(38 mg, 0.15 mmol) in THF (5 mL) was stirred overnight at RT 
whereupon the desired complex precipitated as a white solid.  
The product was isolated by filtration, dried at the pump and 
recrystallized by the slow diffusion of diethyl ether into a 
chloroform solution of the complex. Yield: 88 mg, 64%. 1H NMR 100 
(250 MHz, CD2Cl2) δ 8.79 (d,  4.5 Hz, 2H), 7.99 (t,  7.7 Hz, 
2H), 7.86 (s, 2H), 7.64 (d,  7.7 Hz, 2H), 7.56 – 7.36 (m, 24H), 
7.27 (t,  7.6 Hz, 2H), 7.15 (br, 2H), 6.87 (dd,  10.9, 8.1 Hz, 
2H), 5.12 (q,  6.9 Hz, 2H), 4.69 (br, 2H), 4.46 (br, 2H), 3.50 (br, 
2H), 2.42 (m, 2H), 2.08 (br, 4H), 1.61 (d,  6.9 Hz, 6H), 0.98 (s, 105 
6H), 0.88 (s, 6H), 0.64 (s, 6H) ppm. 31P{1H} NMR (121.7 MHz, 
Acetoned6) δ 14.1 (2 x d, 
1PAg109 751 Hz, 
1PAg107 650 Hz) ppm. 
MS (EI):   1461.31 [L + LH + 2Ag + PF6 + MeCN]
+, 55%. 
[Ag2(AN
MeCHP)2](BF4)2.(PF6)2, 2.BF4 
A solution of [NMeCHP]PF6 (100 mg, 0.15 mmol) and AgBF4 110 
(29 mg, 0.15 mmol) in THF (5 mL) was stirred overnight at RT 
whereupon the desired complex precipitated as a white solid.  
The product was isolated by filtration, dried at the pump and 
recrystallized by the slow diffusion of diethyl ether into a 
chloroform solution of the complex. Yield: 67 mg, 52%. 1H NMR 115 
(250 MHz, Acetoned6) δ 9.08 (d,  5.2 Hz, 2H), 8.26 (s, 2H), 
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8.26 (t,  7.8, 1.5 Hz, 2H), 8.20 – 7.55 (m, 30H), 7.08 (ddd,  
11.7, 7.7, 1.2 Hz, 2H), 5.44 (q,  6.8 Hz, 2H), 4.80 (d,  14.7 Hz, 
2H), 4.36 (d,  14.7 Hz, 2H), 2.97 (br, 2H), 2.71 (m, 2H), 2.25 
(m, 2H), 1.84 (d,  6.8 Hz, 6H), 1.01 (s, 12H), 0.79 (s, 6H) ppm. 
13C{1H} NMR (125.8 MHz, CD2Cl2) δ 156.5 (C), 153.6 (CH), 5 
149.7 (CH), 137.7 (C), 137.3 (d,  12.6 Hz, C), 134.1 (d,  17.5 
Hz, C), 134.0 (d,  16.6 Hz, C), 133.5 (d,  4.9 Hz, CH), 131.5 (d, 
 9.8 Hz, CH), 131.2 (CH), 129.6 (d,  8.6 Hz, CH), 129.5 (d,  
8.5 Hz, CH), 129.0 (d,  7.3 Hz, CH), 128.9 (d,  6.4 Hz, CH), 
123.9 (CH), 122.5 (CH), 72.0 (C), 65.0 (CH), 63.6 (CH), 50.8 10 
(CH2, d,  21.2 Hz), 40.6 (C), 39.1 (CH2), 31.4 (CH2), 20.4 
(CH3), 16.9 (CH3), 16.1 (CH3), 13.7 (CH3) ppm. 
31P{1H} NMR 
(121.7 MHz, CD3CN) δ 14.1 (2 x d, 
1PAg109 750.6 Hz, 
1PAg107 
650.1 Hz) ppm. HRMS (ES):   784.1578 (calc. 784.1574) [LH 
+ Ag + PF6]
+, 95%. Anal. Calcd for 15 
C70H78N6P4B2F20Ag2.0.5CH2Cl2: C, 47.20; H, 4.47; N, 4.72. 
Found: C, 47.1; H, 4.5; N, 4.7. 
[Ag(κNMeCHP)2]BF4.(PF6)2, 3 
A solution of [NMeCHP]PF6 (100 mg, 0.15 mmol) and Ag(BF4) 
(15 mg, 0.075 mmol) in THF (5 mL) was stirred overnight at RT 20 
and the volatiles removed in  to give a white solid that was 
dissolved in CH2Cl2, filtered and taken to dryness to give 3 as a 
white solid. Yield: 99 mg, 86%. 1H NMR (500 MHz, CD2Cl2) δ 
(major isomer) 8.62 (d,  4.4 Hz, 2H), 8.06 (s, 2H), 7.79 (dt,  
7.7, 1.7 Hz, 2H), 7.64 – 7.29 (m, 30H), 7.07 (d,  7.7, 2H), 5.06 25 
(d,  17.5 Hz, 2H), 4.86 (q,  7.0 Hz, 2H), 4.47 (d,  17.5 Hz, 
2H), 3.73 (d,  5.0 Hz, 2H), 2.30 (m, 2H), 2.13 (m, 2H), 2.06 (m, 
2H), 1.67 (d,  7.0 Hz, 6H), 1.55 (m, 2H), 0.92 (s, 6H), 0.65 (s, 
6H), 0.52 (s, 6H),  ppm. 13C{1H} NMR (CD2Cl2, 125.8 MHz) δ 
155.3 (C), 154.7 (br, CH), 149.0 (CH), 137.2 (CH), 134.1 (br, C), 30 
133.3 (br, C), 132.7 (CH), 131.5 (CH), 130.8 (d,  15.5 Hz, CH), 
129.2 (br, CH), 129.0 (br, CH), 123.4 (CH), 121.9 (CH), 71.4 
(C), 63.7 (CH), 63.2 (CH), 50.6 (CH2, br), 40.6 (C), 38.5 (CH2), 
31.2 (CH2), 20.6 (CH3), 16.2 (CH3), 16.1 (CH3), 13.1 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD2Cl2) δ 4.5 (vbr d,  ~ 475 Hz) 35 
ppm. For reasons unknown it proved impossible to obtain MS of 
the compound as, in all cases, only [NMeCHP]+ was observed. 
Anal. Calcd for C70H78N6P4BF16Ag: C, 54.24; H, 5.07; N, 5.42. 
Found: C, 54.5; H, 5.3; N, 5.2. 
[Ag2(AN
MeCP)2](PF6)2, 4 40 
[NMeCHP][PF6] (100 mg, 0.15 mmol) and AgOTf (38 mg, 0.15 
mmol) were dissolved in THF (10 mL) and the solution cooled to 
40 °C whereupon solid KHMDS (33 mg, 0.16 mmol) was added 
and the solution left to slowly warm to RT. After stirring at RT 
for 24 hrs the mixture was filtered and the solvent removed 45 
 to yield an offwhite solid that was washed with diethyl 
ether (2 x 10 mL) and dried at the pump. Recrystallization was 
achieved via the slow diffusion of diethyl ether into a solution of 
the complex in THF to give solventdependent acicular crystals. 
Yield: 57 mg, 52%. 1H NMR (500 MHz, CD2Cl2) δ 7.69 (dt,  50 
7.8, 1.7 Hz, 2H), 7.62 (dt,  7.5, 1.7 Hz, 2H), 7.57 – 7.37 (m, 
20H), 7.09 (m, 10H), 6.47 (dd,  10.9, 7.9 Hz, 2H), 5.30 (m, 4H), 
4.19 (d,  17.7 Hz, 2H), 3.35 (d,  4.4 Hz, 2H), 2.07 (m, 6H), 1.84 
(d,  7.4 Hz, 6H), 1.55 (m, 2H), 0.87 (s, 6H), 0.47 (s, 6H), 0.40 (s, 
6H) ppm. 13C{1H} NMR (150 MHz, CD2Cl2) δ 208.9 (ddd, 55 
(Ag107/109) 194.6, 225.3 Hz, CP 53.6 Hz, C), 158.0 (C), 149.3 
(CH), 141.8 (d,  12.1 Hz, C), 138.2 (CH), 134.7 (d,  16.4 Hz, 
CH), 132.6 (CH), 131.8 (CH), 130.8 (CH), 130.1 (d,  11.0 Hz, 
CH), 129.5 (d,  10.3 Hz, CH), 127.7 (d,  6.6 Hz, CH), 127.7 (d, 
 40.2 Hz, C), 127.2 (d,  40.6 Hz, C), 126.9 (d,  32.0 Hz, C), 60 
126.1 (d,  7.2 Hz, CH), 124.1 (CH), 120.8 (CH), 70.1 (C), 68.2 
(CH), 64.1 (CH), 55.6 (d,  21.1 Hz, CH2), 41.0 (C), 39.4 (CH2), 
32.2 (CH2), 21.8 (CH3), 18.3 (CH3), 15.9 (CH3), 14.4 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD2Cl2) δ 3.39 (2 x d, 
1PAg109 539 
Hz, 1PAg107 468 Hz) ppm. HRMS (ES):   784.1583 (calc. 65 
784.1574) [LH + Ag + PF6]
+, 95%; 638.1871 (calc. 638.1854) [L 
+ Ag]+, 90%. Anal. Calcd for C70H76N6P4F12Ag2: C, 53.59; H, 
4.88; N, 5.36. Found: C, 53.4; H, 4.8; N, 5.3.  
[Au(κNMeCHP)Cl]PF6, 5 
A solution of [NMeCHP]PF6 (100 mg, 0.15 mmol) and 70 
Au(THT)Cl (48 mg, 0.15 mmol) in THF (5 mL) was stirred 
overnight at RT and the volatiles removed in  to give a 
white solid that was triturated with dry diethyl ether and dried at 
the pump. Yield: 138 mg, 93%. 1H NMR (400 MHz, CD2Cl2) δ 
(major isomer) 8.47 (d,  4.3 Hz, 1H), 7.85 (s, 1H), 7.72 (dt,  75 
7.7, 1.7 Hz, 1H), 7.65 – 7.27 (m, 14H), 7.25 (ddd,  7.7, 4.9, 1.0 
Hz, 1H), 6.78 (ddd,  13.0, 7.8, 1.0 Hz, 1H), 5.11 (d,  15.2 Hz, 
1H), 4.84 (q,  7.0 Hz, 1H), 4.51 (d,  15.2 Hz, 1H), 3.79 (d,  4.6 
Hz, 1H), 2.46 (m, 1H), 2.08 (m, 2H), 1.88 (m, 1H), 1.62 (d,  7.0 
Hz, 3H), 1.01 (s, 3H), 0.94 (s, 3H), 0.55 (s, 3H),  ppm. 13C{1H} 80 
NMR (CD2Cl2, 125.8 MHz) δ 155.2 (C), 153.3 (CH), 148.9 (CH), 
137.1 (CH), 134.0 (d,  14.1 Hz, C), 133.7 (d,  14.0 Hz, C), 
133.4 (d,  7.2 Hz, C), 132.1 (br, C), 131.9 (d,  2.0 Hz, CH), 
129.3 (d,  12.4 Hz, CH), 129.1 (d,  12.1 Hz, CH), 128.5 (d,  
9.2 Hz, CH), 126.4 (d,  33.9 Hz, CH), 125.9 (d,  34.0 Hz, CH), 85 
125.4 (d,  57.4 Hz, CH), 123.4 (CH), 122.2 (CH), 72.1 (C), 63.8 
(CH), 63.3 (CH), 49.7 (d,  14.6 Hz, CH2), 40.5 (C), 39.1 (CH2), 
31.6 (CH2), 20.6 (CH3), 16.9 (CH3), 15.9 (CH3), 14.3 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD2Cl2) δ 25.0 ppm. HRMS (ES+): 
  764.2230 (calc. 764.2236) [LH + Au + Cl]+, 100%. Anal. 90 
Calcd for C35H39N3P2F6ClAu: C, 46.19; H, 4.32; N, 4.62%. 
Found: C, 46.1; H, 4.3; N, 4.5%. 
[Au(κNMeCHP)2]Cl.(PF6)2, 6 
A solution of [NMeCHP]PF6 (100 mg, 0.15 mmol) and 
Au(THT)Cl (24 mg, 0.075 mmol) in THF (5 mL) was stirred 95 
overnight at RT and the volatiles removed in  to give a 
white solid that was dissolved in a 1:1 mixture of Et2O and 
CH2Cl2 and set aside at 20° C. The microcrystalline solid that 
formed was isolated by filtration and dried at the pump. Yield: 
105 mg, 64%. 1H NMR (400 MHz, d6acetone) δ (major isomer) 100 
8.66 (d,  4.8 Hz, 2H), 8.40 (s, 2H), 7.90 (dt,  7.6, 1.8 Hz, 2H), 
7.73 (m, 4H), 7.65 – 7.38 (m, 26H), 6.99 (t,  8.7, 2H), 5.13 (m, 
4H), 5.07 (q,  7.0 Hz, 2H), 3.88 (d,  5.0 Hz, 2H), 2.57 (m, 2H), 
2.17 (m, 2H), 2.08 (m, 2H), 1.93 (m, 1H), 1.74 (d,  7.0 Hz, 3H), 
1.19 (s, 3H), 1.06 (s, 3H), 0.77 (s, 3H),  ppm. 13C{1H} NMR (d6105 
acetone, 125.8 MHz) δ 157.7 (C), 155.4 (CH), 150.6 (CH), 139.6 
(d,  16.0 Hz, C), 138.6 (CH), 136.0  130.0 (3 x C, 13 x CH), 
124.9 (CH), 123.6 (CH), 73.4 (C), 66.5 (CH), 64.8 (CH), 51.8 
(CH2, d,  21.0 Hz), 42.0 (C), 40.5 (CH2), 32.6 (CH2), 21.7 
(CH3), 18.3 (CH3), 17.4 (CH3), 15.5 (CH3) ppm. 
31P{1H} NMR 110 
(121.7 MHz, CD2Cl2) δ 9.6 (br) ppm. HRMS (ES+):   
1441.4806 (calc. 1441.4759) [2LH + Au + PF6 + Cl]
+, 100%. 
Anal. Calcd for C70H78N6P4F12ClAu: C, 52.95; H, 4.95; N, 
5.29%. Found: C, 52.8; H, 5.0; N, 5.3%. 
[Au2(AN
MeCP)2](PF6)2, 7 115 
[NMeCHP][PF6] (100 mg, 0.15 mmol) and Au(THT)Cl (48 mg, 
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0.15 mmol) were dissolved in THF (10 mL) and the solution 
stirred for 20 mins at RT before adding solid KHMDS (33 mg, 
0.16 mmol) in one portion. The solution was left to stir for a 
further 24 hrs at RT, filtered and the solvent removed  to 
yield an offwhite solid that was washed with diethyl ether (2 x 5 
10 mL) and dried at the pump. Recrystallization was achieved via 
the slow diffusion of diethyl ether into a saturated solution of 
acetone. Yield: 101 mg, 77%. 1H NMR (500 MHz, CD2Cl2) δ 
8.06 (d,  5.0, 2H), 7.61 (dt,  7.5, 1.7 Hz, 2H), 7.58 – 7.41 (m, 
18H), 7.37 (dt,  7.7, 1.8 Hz, 2H), 7.31 (d,  7.1 Hz, 2H), 7.28 (d, 10 
 7.4 Hz, 2H), 7.16 (d,  7.8 Hz, 2H), 7.07 (dd,  7.6, 4.8 Hz, 2H), 
7.02 (t,  7.4 Hz, 2H), 6.45 (dd,  13.2, 7.6 Hz, 2H), 5.98 (q,  7.2 
Hz, 2H), 5.64 (d,  18.3 Hz, 2H), 4.04 (d,  18.3 Hz, 2H), 3.59 (d, 
 4.0 Hz, 2H), 2.06 (m, 6H), 1.79 (d,  7.2 Hz, 6H), 1.44 (m, 2H), 
0.76 (s, 6H), 0.31 (s, 6H), 0.25 (s, 6H) ppm. 13C{1H} NMR (150 15 
MHz, CD2Cl2) δ 206.4 (d, CP 119.0 Hz, C), 157.6 (C), 149.4 
(CH), 141.9 (d,  10.7 Hz, C), 137.1 (CH), 134.9 (d,  13.3 Hz, 
C), 134.7 (br, C), 133.4 (CH), 132.8 (d,  7.2 Hz, C), 132.6 (CH), 
131.5 (CH), 130.3 (d,  11.6 Hz, CH), 129.7 (d,  11.6 Hz, CH), 
127.7 (d,  8.9 Hz, CH), 126.6 (d,  9.0 Hz, CH), 126.5 (d,  10.0 20 
Hz, CH), 126.2 (d,  11.0 Hz, CH), 125.5 (CH), 123.7 (CH), 
121.4 (CH), 71.8 (C), 67.2 (CH), 62.8 (d,  3.3 Hz, CH2), 41.0 
(C), 38.9 (CH2), 31.8 (CH2), 22.0 (CH3), 17.8 (CH3), 15.8 (CH3), 
14.1 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD2Cl2) δ 30.4 
ppm. HRMS (ES+):  1601.4553 (calc. 1601.4580) [2L + 2Au 25 
+ PF6]
+, 40%; 728.2456 (calc. 728.2463) [2L + 2Au]+, 100%. 
Anal. Calcd for C70H76N6P4F12Au2.THF: C, 48.85; H, 4.65; N, 
4.62%. Found: C, 48.9; H, 4.5; N, 4.6%. 
[Au(κNMeCP)2]PF6, 8 
[NMeCHP][PF6] (100 mg, 0.15 mmol) and Au(THT)Cl (24 mg, 30 
0.075 mmol) were added to THF (10 mL) and left to stir for 24 h 
at RT whereupon KHMDS (33 mg, 0.16 mmol) was added as a 
solid. The reaction mixture was left to stir for 24 h, the solution 
filtered and the volatiles removed to give a light yellow 
solid. The solid was washed with diethyl ether (2 x 10 mL) and 35 
subsequently recrystallized via slow diffusion of diethyl ether 
into a saturated acetone solution of the complex. Yield: 93 mg, 
81%.  1H NMR (500 MHz, d6acetone) δ 8.68 (d,  4.1 Hz, 2H), 
7.87 (br, 2H), 7.63 (br, 2H), 7.58 (br, 2H), 7.40 (m, 12H), 7.26 
(m, 8H), 7.13 (t,  5.3 Hz, 2H), 7.00 (br, 2H), 6.84 (dd,  7.1, 4.7 40 
Hz, 2H), 5.75 (q br,  7.2 Hz, 2H), 5.20 (br, 4H), 3.64 (d,  5.4 
Hz, 2H), 2.35 (br, 2H), 2.21 (br, 2H), 1.85 (br, 2H), 0.81 (s, 12H), 
0.33 (s, 6H) ppm. 13C{1H} NMR (150 MHz, d6acetone) δ 202.8 
(C), 158.6 (C), 150.2 (CH), 143.4 (d,  21.3 Hz, C), 138.0 (CH), 
135.0 (d, , 19.7 Hz, C), 134.6 (d,  19.7 Hz, C), 134.2 (s, CH), 45 
130.3 (d,  12.6 Hz, CH), 129.8 (d,  3.8 Hz, CH), 129.8 (d,  3.6 
Hz, CH), 128.5 (CH), 126.6 (br, C), 124.5 (CH), 123.9 (CH), 
72.9 (C), 67.0 (CH), 62.7 (CH2), 41.1 (C), 39.9 (CH2), 33.1 
(CH2), 22.1 (CH3), 18.4 (CH3), 16.9 (CH3), 16.0 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, d6acetone) δ 17.0 (br) ppm. HRMS 50 
(ES+):  1291.5125 (calc. 1291.5171) [2L + Au + 2O]+, 100%; 
1275.5201 (calc. 1275.5222) [2L + Au + O]+, 70%; 1259.5305 
(calc. 1259.5272) [2L + Au]+, 25%. Anal. Calcd for 
C70H76N6P3F6Au: C, 59.83; H, 5.45; N, 5.98%. Found: C, 59.5; 
H, 5.4; N, 5.9%. 55 
[Ni(κ3NMeCP)(η3C8H13)]PF6, 9 
A solution of [NMeCHP][PF6] (100 mg, 0.15 mmol) and 
[Ni(1,5COD)2] (41 mg, 0.075 mmol) in THF (10 mL) was left to 
stir for 24 h at RT before removing all volatiles at the pump. The 
resulting yellow solid was washed with diethyl ether (2 x 10 mL) 60 
and dried at the pump. Yield: 115 mg, 91%.  1H NMR (500 MHz, 
CD2Cl2) δ 8.45 (d,  4.7 Hz, 1H), 7.57 (m, 6H), 7.45 (m, 1H), 
7.41 (t,  7.6 Hz, 1H), 7.25 (m, 5H), 7.15 (m, 3H), 6.98 (d,  8.0 
Hz, 1H), 6.78 (d,  15.2 Hz, 1H), 5.09 (t,  8.4 Hz, 1H), 4.79 (d,  
15.0 Hz, 1H), 4.54 (q,  7.2 Hz, 1H), 4.44 (q,  8.8 Hz, 1H), 3.89 65 
(m, 1H), 3.59 (d,  5.3 Hz, 1H), 2.09 (m, 1H), 1.80 (m, 1H), 1.73
0.94 (m, 12H), 1.44 (s, 3H), 0.87 (s, 3H), 0.75 (s, 3H), 0.20 (d,  
7.0 Hz, 3H) ppm. 13C{1H} NMR (150 MHz, d8THF) δ 202.1 (d, 
 16.6 Hz, C), 159.3 (C), 146.7 (CH), 143.9 (d,  15.2 Hz, C), 
137.0 (CH), 135.6 (d,  41.7 Hz, C), 135.2 (CH), 131.4 (d,  11.0 70 
Hz, C), 130.2 (CH), 129.5 (d,  8.5 Hz, CH), 129.4 (d,  11.0 Hz, 
CH), 129.0 (CH), 128.3 (C), 128.0 (d,  9.7 Hz, CH), 127.5 (CH), 
127.0 (d,  6.3 Hz, CH), 120.7 (CH), 119.7 (CH), 109.5 (CH), 
87.5 (CH), 75.9 (C), 68.7 (CH), 62.8 (CH2), 61.8 (CH2), 54.8 (d, 
 9.5 Hz, CH2), 40.1 (C), 37.1 (CH2), 30.7 (CH2), 30.3 (CH2), 75 
29.2 (CH2), 28.4 (CH2), 21.2 (CH3), 19.5 (CH3), 17.3 (CH3), 16.4 
(CH3), 14.0 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD2Cl2) δ 
13.1 ppm. HRMS (ES+):   698.3165 (calc. 698.3174) [L + Ni 
+ C8H13]
+, 100%. Unfortunately, despite multiple attempts, 
acceptable analytical data could not be obtained for this complex.  80 
[Ni(κ3NMeCP)(Cl)]PF6, 10 
A solution of 9 (40 mg, 0.47 x 104 mol) was stirred in CHCl3 (3 
mL) under air for 24 h, filtered and the yellow solution taken to 
dryness. The residual solid was recrystallized from MeOH to give 
small orange crystals of 10. Yield: 9 mg, 22%.  1H NMR (500 85 
MHz, CD2Cl2) δ (major isomer) 8.83 (d,  5.8 Hz, 1H), 8.07.0 
(m, 17H), 6.25 (q,  7.0 Hz, 1H), 4.81 (d,  15.4 Hz, 1H), 2.92 (d, 
 4.9 Hz, 1H), 1.800.74 (m, 4H), 1.47 (s, 3H), 1.35 (d,  7.0 Hz, 
3H), 0.74 (s, 3H), 0.30 (s, 3H) ppm. Due to the small scale of the 
reaction and the fact that the complex appeared unstable in 90 
solution over time (see main text) we were unable to get 
satisfactory 13C{1H} NMR data for 10. 31P{1H} NMR (121.7 
MHz, CD2Cl2) δ 8.0 (minor), 5.2 (major) ppm. HRMS (ES+):   
624.1868 (calc. 624.1845) [L + Ni + Cl]+, 100%.  Anal. Calcd for 
C35H38N3P2F6ClNi: C, 54.54; H, 4.97; N, 5.45%. Found: C, 54.5; 95 
H, 5.1; N, 5.5%.  
[Pt(κNMeCHP)2Cl2](PF6)2, 11 
A mixture of [NMeCHP]PF6 (100 mg, 0.15 mmol) and 
K2[PtCl4] (31 mg, 0.075 mmol) was heated near reflux in EtOH 
(10 mL) for 18 hrs. After cooling, the white solid was isolated by 100 
filtration and recrystallized from MeCN. Yield: 65 mg, 53%. A 
second crop was obtained upon leaving the filtrate to slowly 
evaporate. Yield = 25%. 1H NMR (400 MHz, CD3CN) δ (major 
isomer) 8.48 (d,  4.8 Hz, 2H), 7.95 (m, 8H), 7.76 (dt,  7.5, 1.3 
Hz, 2H), 7.61 (m, 14H), 7.44 (t,  7.5 Hz, 2H), 7.31 (m, 6H), 7.20 105 
(m, 2H), 4.76 (d,  16.0 Hz, 2H), 4.65 (d, J 16.0 Hz, 2H), 4.64 
(obs, 2H), 3.57 (d,  5.1 Hz, 2H), 2.05 (m, 4H), 1.78 (m, 4H), 
1.45 (d,  7.4 Hz, 6H), 1.00 (s, 6H), 0.95 (s, 6H), 0.57 (s, 6H),  
ppm. 13C{1H} NMR (CD3CN, 75.6 MHz) δ 156.1 (C), 152.0 (d, J 
2.9 Hz, CH), 149.7 (d, J 2.3 Hz, CH), 137.7 (C), 137.3 (C), 135.4 110 
(br), 134.0 (br), 131.9 (br), 129.2 (br), 128.7 (CH), 124.0 (CH), 
122.4 (CH), 72.2 (C), 65.6 (CH), 63.5 (CH), 50.4 (br, CH2), 40.7 
(C), 39.2 (CH2), 31.8 (CH2), 20.7 (CH3), 17.5 (CH3), 16.3 (CH3), 
13.8 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD3CN) δ 17.1 (
1P
Pt 2570 Hz) ppm. HRMS (ES+):  664.7383 (calc. 664.7394) 115 
([2LH + Pt + 2Cl]2+, 100%. Anal. Calcd for C70H78N6P4F12Cl2Pt: 
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C, 51.86; H, 4.85; N, 5.18%. Found: C, 51.9; H, 5.0; N, 5.2%. 
[Pt(κ3NMeCP)Cl]PF6, 12 
A solution of 11 (100 mg, 6.2 x 105 mol) in THF (20 mL) was 
cooled to 78 ⁰C whereupon KHMDS (30 mg, 1.5 x 104 mol) 
was added as a solid. The solution was stirred for 20 mins at this 5 
temperature before being allowed to warm to RT and stirring 
continued overnight. On return the mixture was exposed to air 
and allowed to slowly evaporate on the bench. Initial powdery 
precipitates were filtered off and discarded before the desired 
complex was formed, after evaporation of most of the solvent, as 10 
large colourless crystals. Yield: 41 mg, 73%. 1H NMR (500 MHz, 
d6acetone) δ 9.04 (br, 1H), 8.20 (t,  7.8 Hz, 1H), 7.80 (m, 3H), 
7.63 (m, 6H), 7.35 (m, 6H), 7.21 (dd,  11.0, 8.1 Hz, 1H), 6.82 (d, 
 15.9 Hz, 1H), 4.99 (d, J 15.9 Hz, 1H), 4.95 (q,  7.2 Hz, 1H), 
3.46 (d,  4.1 Hz, 1H), 2.28 (m, 1H), 1.88 (m obs, 1H), 1.88 (d, J 15 
7.2 Hz, 3H), 1.53 (m, 1H), 1.27 (s, 3H), 0.90 (s, 3H), 0.44 (s, 3H) 
ppm. 13C{1H} NMR (150 MHz, d6acetone) δ 170.6 (d, 
2CP 6.7 
Hz, C), 157.7 (C), 152.9 (CH), 143.2 (d,  10.9 Hz, C), 141.5 
(CH), 137.2 (d,  3.2 Hz, CH), 134.2 (d,  10.5 Hz, C), 132.7 (d,  
10.0 Hz, C), 131.8 (3 x CH), 131.5 (CH), 130.3 (d,  2.4 Hz, CH), 20 
129.0 (d,  11.0 Hz, CH), 128.6 (d,  8.6 Hz, CH), 127.8 (d,  
11.9 Hz, CH), 125.4 (d,  2.8 Hz, CH), 123.7 (d,  2.8 Hz, CH), 
73.2 (C), 73.2 (CH), 68.2 (CH), 55.1 (d,  8.9 Hz, CH2), 41.3 (C), 
38.8 (CH2), 31.2 (CH2), 22.3 (CH3), 21.1 (CH3), 17.3 (CH3), 16.5 
(CH3) ppm. 
31P{1H} NMR (121.7 MHz, d6acetone) δ 7.8 (
1PPt 25 
3661 Hz) ppm. HRMS (ES+):  761.2125 (calc. 761.2140) [L + 
Pt + Cl]+, 100%. Anal. Calcd for C35H38N3P2F6ClPt.THF: C, 
47.83; H, 4.74; N, 4.29%. Found: C, 47.5; H, 4.6; N, 4.4%. 
[Rh(κNMeCHP)(acac)CO]PF6, 13 
To a solution of [Rh(acac)CO]2 (35 mg, 0.075 mmol) in THF (10 30 
mL) was added solid [NMeCHP]PF6 (100 mg, 0.15 mmol). The 
addition gave an immediate effervescence and after stirring for 10 
mins the volatiles were removed in  to give the desired 
compound as a yellow solid. Yield = 130 mg (96%). 1H NMR 
(400 MHz, CDCl3) δ (major isomer) 8.46 (d,  4.0 Hz, 1H), 7.88 35 
(s, 1H), 7.71 (dt,  7.9, 1.8 Hz, 1H), 7.637.31 (m, 14H), 7.22 (m, 
1H), 6.82 (dd,  11.1, 7.7 Hz, 1H), 4.76 (d,  16.0 Hz, 2H), 5.74 
(d,  16.0 Hz, 1H), 4.88 (q,  7.2 Hz, 1H), 4.82 (d,  16.0 Hz, 
1H), 3.88 (d,  5.3 Hz, 1H), 2.26 (m, 1H), 2.00 (s, 3H), 1.99 (s, 
3H), 1.87 (m, 1H), 1.68 (m, 2H), 1.60 (d,  7.2 Hz, 3H), 1.10 (s, 40 
3H), 0.92 (s, 3H), 0.48 (s, 3H), ppm. 13C{1H} NMR (CDCl3, 75.6 
MHz) δ 189.1 (dd, 1CRh 75.4 Hz, 
2CP 24.2 Hz, CO), 188.1 
(C=O), 185.4 (C=O), 156.2 (C), 153.1 (CH), 149.6 (CH), 138.1 
(CH), 137.1 (d,  10.8 Hz, C), 135.2 (d,  11.4 Hz, CH), 134.3 (d, 
 11.4 Hz, C), 132.9 (d,  6.0 Hz, C), 131.4 (CH), 131.1 (CH), 45 
129.5 (d,  6.6 Hz, C), 129.0 (CH), 128.8 (CH), 128.7 (CH), 
128.6 (CH), 124.1 (CH), 123.1 (CH), 101.0 (CH), 72.5 (C), 64.1 
(CH), 63.9 (CH), 50.9 (d,  13.2 Hz, CH2), 41.1 (C), 39.3 (CH2), 
32.3 (CH2), 27.7 (CH3), 27.6 (CH3), 21.6 (CH3), 17.8 (CH3), 16.7 
(CH3), 14.7 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, CD3CN) δ 50 
42.8 (1PRh 169 Hz) ppm. HRMS (ES+):   762.2358 (calc. 
762.2332) [LH + Rh + acac + CO]+, 100%. Anal. Calcd for 
C41H46N3P2O3F6Rh: C, 54.25; H, 5.11; N, 4.63%. Found: C, 53.9; 
H, 5.4; N, 4.8%. 
[Rh(κ3NMeCP)(CO)]PF6, 14 55 
A solution of 13 (70 mg, 7.7 x 105 mol) in C6H5Cl (1 mL) in a 
Young’s type NMR tube was heated to 140 ⁰C (oil bath 
temperature) for two hours. Inspection of the yellow solution at 
this stage by 31P{1H} NMR showed complete disappearance of 
the signal for 13 and the presence of two new doublets at 27.2 60 
(minor, 1PRh 162 Hz) and 25.4 (major, 
1PRh 165 Hz) ppm. The 
mixture was filtered and the volatiles removed in  to yield 
an orange solid which was washed quickly with cold CHCl3 (1 
ml) to leave a microcrystalline solid. Yield: 25 mg, 40%. The 
compound could be recrystallized from MeOH in very low yield, 65 
sufficient for 1H and 31P{1H} NMR spectroscopy and 
microanalysis only. 1H NMR (500 MHz, d6acetone, ~1:1 
isomeric mixture) δ 9.13 (br, 1H), 9.05 (br, 1H), 8.16 (m, 2H), 
7.87 – 7.36 (m, 30H), 7.16 (m, 2H), 7.05 (d,  15.4 Hz, 1H), 6.90 
(d,  15.4 Hz, 1H), 5.92 (q,  7.5 Hz, 1H), 4.92 (d,  15.4 Hz, 70 
1H), 4.85 (q,  7.1 Hz, 1H), 4.69 (d,  15.4 Hz), 3.29 (d,  4.7 Hz, 
1H), 3.26 (d,  4.5 Hz, 1H), 2.20 (m, 1H), 1.82 (m, 4H), 1.59 (d,  
7.4 Hz, 3H), 1.46 (m, 3H), 1.46 (s, 3H), 1.23 (s, 3H), 0.88 (s, 
3H), 0.85 (s, 3H), 0.29 (s, 3H), 0.01 (s, 3H) ppm. 13C{1H} NMR 
(150 MHz, CDCl3, ~3:1 isomeric mixture: major isomer unless 75 
stated otherwise) δ 203.9 (dd, 1CRh 40.4 Hz, 
2CP 11.3 Hz, CO), 
202.1 (dd, 1CRh 38.2 Hz, 
2CP 13.5 Hz, CO, minor), 192.4 (dd, 
1CRh 61.2 Hz, 
2CP 13.9 Hz, C, minor), 191.4 (dd, 
1CRh 60.4 
Hz, 2CP 16.6 Hz, C), 160.7 (C), 154.9 (CH), 143.9 (d,  13.3 Hz, 
C), 140.1 (CH), 137.0 (CH), 135.0 – 128.0 (aromatics), 126.5 80 
(CH), 71.8 (C), 71.3 (CH), 68.0 (CH), 56.8 (d,  10.0 Hz, CH2), 
41.5 (C), 39.0 (CH2), 31.4 (CH2), 26.2 (CH3), 21.9 (CH3), 17.4 
(CH3), 16.9 (CH3) ppm. 
31P{1H} NMR (121.7 MHz, d6acetone, 
~1:1 isomeric mixture) δ 28.7 (1PRh 166 Hz), 27.2 (
1PRh 165 
Hz) ppm. HRMS (ES+):  662.1829 (calc. 662.1808) [L + Rh + 85 
CO]+, 100%. Anal. Calcd for C36H38N3P2F6ORh: C, 53.54; H, 
4.74; N, 5.20%. Found: C, 53.1; H, 4.6; N, 5.3%. It is of interest 
to note that if the reaction is performed in C6H5Cl that has not 
been predried, the PF6
 anion is hydrolysed to PO2F2
. 
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Graphical Abstract 
 
Mono and dimeric complexes of an asymmetric heterotopic P,CNHC,pyr ligand 
 
Mathilde Bouché, Michael Mordan, Benson M. Kariuki, Simon J. Coles, Jeppe 
Christensen and Paul D. Newman* 
 
An asymmetric tridentate ligand with three different donors coordinates to Ag(I) and 
Au(I) to give discreet ligandbridged dimers or κ
1
 species whilst full κ
3
binding 
occurs with Ni(II), Pt(II) and Rh(I).  
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